Peroxynitrite - Matrix Metalloproteinase and Erythropoietin Receptor Signaling Pathways in Ischemic Heart Disease

doi 10.14232/phd.3958

Full Text

Abstract

Available in

Date

Unknown

Authors

Publisher

University of Szeged

Related search

Matrix Metalloproteinase Therapy in Heart Failure

Current Treatment Options in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2009English

Signalling Pathways Involved in the Tissue-Protective Effects of Erythropoietin and Erythropoietin-Derivatives in Ischemic Human Myotubes

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Ischemic Heart Disease.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1998German

Advantages of Fast-Acting ADP Receptor Blockade in Ischemic Heart Disease

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2003English

Erythropoietin Receptor Signaling Is Membrane Raft Dependent

PLoS ONE
Multidisciplinary
2012English

Apoptosis in Ischemic Heart Disease

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Sugar and Ischemic Heart Disease.

BMJ
1969English

Insights Into Causal Pathways for Ischemic Heart Disease: Adverse Childhood Experiences Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy